佐久間健二

研究者氏名	佐久間健二
	サクマケンジ
URL	https://nrid.nii.ac.jp/ja/nrid/1000070838317/
所属	藤田医科大学
部署	医学部医学科精神神経科学
職名	講師
学位	博士（医学）
J-Global ID	201601006206149436

研究分野

ライフサイエンス / 精神神経科学 /

経歴

藤田医科大学医学部精神神経科学講座講師

論文

12 3 4 5 >

Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta-analysis.

Taro Kishi Kenji Sakuma Masakazu Hatano Takenori Okumura Masaki Kato Hajime Baba Nakao Iwata

Neuropsychopharmacology reports 2024年2月

AIM: To update the major depressive disorder (MDD) treatment guidelines of the Japanese Society of Mood Disorders, we conducted a systematic review and pairwise meta-analysis of double-blind, randomized, placebo-controlled trials of available anti...

Safety profile of antidepressant for Japanese adults with major depressive disorder: a systematic review and network meta-analysis.

Taro Kishi Toshikazu Ikuta Kenji Sakuma Masakazu Hatano Yuki Matsuda Satoru Esumi Nobumi Miyake Itaru Miura Masaki Kato Nakao Iwata

Psychiatry and clinical neurosciences 2023年11月

Serotonin 3 receptor antagonists for obsessive-compulsive disorder: A systematic review and pairwise meta-analysis.

Shun Hamanaka Taro Kishi Kenji Sakuma Yasufumi Nishii Masakazu Hatano Nakao Iwata

Journal of psychiatric research 167 132-138 2023年10月

The benefits of serotonin 3 receptor antagonists (5-HT3R-As) in obsessive-compulsive disorder (OCD) treatment remain unclear. Thus, this study aimed to perform a systematic review and a random-effects meta-analysis, including double-blind, randomi...

Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta-analysis.

Taro Kishi Kenji Sakuma Masakazu Hatano Yuki Matsuda Satoru Esumi Nobumi Miyake Itaru Miura Hikaru Hori Masaki Kato Nakao Iwata

Neuropsychopharmacology reports 2023年8月

INTRODUCTION: The question remains to be elucidated: "Is treatment with antidepressants at doses approved in Japan effective for Japanese patients with MDD?" It is crucial to confirm this in order to provide appropriate treatments for Japanese pat...

Intermittent theta burst stimulation vs. high-frequency repetitive transcranial magnetic stimulation for major depressive disorder: A systematic review and meta-analysis.

Taro Kishi Kenji Sakuma Yuki Matsuda Shinsuke Kito Nakao Iwata

Psychiatry research 328 115452-115452 2023年8月

Our meta-analysis demonstrated that intermittent theta burst stimulation (iTBS)/bilateral-TBS (Bi-TBS) and high-frequency repetitive transcranial magnetic stimulation (HF-rTMS)/bilateral-rTMS (Bi-rTMS) had similar efficacy, acceptability, and safe...